Liquidia (LQDA) Change in Accured Expenses (2020 - 2026)
Liquidia (LQDA) posted Change in Accured Expenses of $34.0 million for Q2 2026, up 133.76% on a QoQ basis from $14.5 million in Q1 2026, and up 291.31% year-over-year from $8.7 million in Q2 2025.
Analysis
Liquidia (LQDA) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Liquidia has reported Change in Accured Expenses for 7 years, with the latest figure at $34.0 million in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 291.31% year-over-year to $34.0 million in Q2 2026; TTM through Jun 2026 was $99.2 million, a 952.61% increase from a year earlier, with the FY2025 full-year figure at $54.5 million, up 937.04% from the prior year.
- Change in Accured Expenses was $34.0 million for Q2 2026 at Liquidia, up from $14.5 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $34.0 million in Q2 2026, with the low at -$4.8 million in Q1 2025.
- Average Change in Accured Expenses over 5 years is $6.5 million, with a median of $1.8 million recorded in 2023.
- The largest YoY upside for Change in Accured Expenses was 1913.33% in 2023 against a maximum downside of 3781.43% in 2023.
- Over 5 years, Change in Accured Expenses stood at $330000.0 in 2022, then soared by 1913.33% to $6.6 million in 2023, then slumped by 70.38% to $2.0 million in 2024, then jumped by 1564.28% to $32.8 million in 2025, then grew by 3.72% to $34.0 million in 2026.
- The last three Change in Accured Expenses figures came in at $34.0 million (Q2 2026), $14.5 million (Q1 2026), and $32.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | 2.32 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | 1.20 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 55.78 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | -204.33 Mn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | -4.00 Mn |
| 10 | Liquidia | 6.11 Bn | 5.82 Bn | 160.92 Mn | 33.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.97 Mn |
| Mar 31, 2026 | 14.53 Mn |
| Dec 31, 2025 | 32.75 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Mar 31, 2025 | -4.82 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | -968,000.00 |
| Mar 31, 2024 | 668,000.00 |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.82 Mn |
| Mar 31, 2023 | -2.58 Mn |
| Dec 31, 2022 | 330,000.00 |
| Sep 30, 2022 | 936,000.00 |
| Jun 30, 2022 | -791,000.00 |
| Mar 31, 2022 | 70,000.00 |
| Dec 31, 2021 | 790,000.00 |
| Sep 30, 2021 | 1.01 Mn |